InsidersTradesSigma
Beijing Biostar Pharmaceuticals Co., Ltd. - B Stock: price and management transactions · Hong Kong · HKEX
Follow the Beijing Biostar Pharmaceuticals Co., Ltd. - B share price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are quoted on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Beijing Biostar Pharmaceuticals Co., Ltd. - B has published 2 public disclosures. Market capitalisation: €1.4bn. The latest transaction was filed on 8 May 2026 (Purchase). Among the most active insiders: Tang Li. All data is accessible without an account.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
4Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,613 of 26,132 companies
34.6
score / 100
Value14
Quality55
FCF yld-13%
Earn yld-11%
EV/EBITDA·
ROE-18%
Gross mgn92%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 May 2026
Declarations2 total
57,830,299 sharesShareXHKGHKEX:DA20260508E00311
Ideal exit: 26 Dec 2026 (T+270)
2 of 2 declarations